Autobacs Seven Co., Ltd. (TYO:9832)
Japan · Delayed Price · Currency is JPY 1,603.00
+41.00 (2.62%)
Nov 5, 2026, 3:30 PM JST
Autobacs Seven Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 292,408 | 280,055 | 249,525 | 229,856 | 236,235 | 228,586 | |
Revenue Growth | 9.08% | 12.23% | 8.56% | -2.70% | 3.35% | 3.69% |
Cost of Revenue | 186,942 | 179,919 | 161,152 | 154,432 | 156,773 | 151,436 |
Gross Profit | 105,466 | 100,136 | 88,373 | 75,424 | 79,462 | 77,150 |
Selling, General & Admin | 85,775 | 80,420 | 71,113 | 63,011 | 63,835 | 61,805 |
Operating Expenses | 91,695 | 86,340 | 76,247 | 67,414 | 67,739 | 65,598 |
Operating Income | 13,771 | 13,796 | 12,126 | 8,010 | 11,723 | 11,552 |
Interest Expense | -497 | -416 | -168 | -91 | -69 | -76 |
Interest & Investment Income | 269 | 208 | 252 | 211 | 147 | 130 |
Earnings From Equity Investments | -380 | 292 | 433 | 99 | -509 | -672 |
Currency Exchange Gain (Loss) | 284 | 284 | - | - | - | - |
Other Non Operating Income (Expenses) | 710 | 527 | -58 | -86 | 416 | 441 |
EBT Excluding Unusual Items | 14,157 | 14,691 | 12,585 | 8,143 | 11,708 | 11,375 |
Gain (Loss) on Sale of Investments | 397 | 397 | 898 | -351 | - | - |
Gain (Loss) on Sale of Assets | -90 | -67 | -70 | -50 | -133 | -130 |
Asset Writedown | -1,188 | -1,188 | -462 | -534 | -897 | -238 |
Other Unusual Items | 534 | 534 | - | 3,075 | 1,177 | - |
Pretax Income | 13,810 | 14,367 | 12,951 | 10,283 | 11,855 | 11,007 |
Income Tax Expense | 1,923 | 5,991 | 4,803 | 3,915 | 4,640 | 3,990 |
Earnings From Continuing Operations | 11,887 | 8,376 | 8,148 | 6,368 | 7,215 | 7,017 |
Minority Interest in Earnings | -48 | -24 | -16 | -13 | 24 | -7 |
Net Income | 11,839 | 8,352 | 8,132 | 6,355 | 7,239 | 7,010 |
Net Income to Common | 11,839 | 8,352 | 8,132 | 6,355 | 7,239 | 7,010 |
Net Income Growth | 18.46% | 2.71% | 27.96% | -12.21% | 3.27% | -0.57% |
Shares Outstanding (Basic) | 79 | 79 | 78 | 78 | 78 | 79 |
Shares Outstanding (Diluted) | 79 | 79 | 78 | 78 | 78 | 79 |
Shares Change | 0.06% | 0.30% | 0.41% | 0.02% | -0.86% | -1.55% |
EPS (Basic) | 150.76 | 106.37 | 103.89 | 81.52 | 92.88 | 89.16 |
EPS (Diluted) | 150.76 | 106.37 | 103.89 | 81.52 | 92.88 | 89.16 |
EPS Growth | 18.39% | 2.39% | 27.44% | -12.23% | 4.16% | 1.00% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -2,423 | -4,982 | 5,282 | 3,505 | -588 |
Free Cash Flow Per Share | - | -30.86 | -63.65 | 67.76 | 44.97 | -7.48 |
Dividend Per Share | 60.000 | 60.000 | 60.000 | 60.000 | 60.000 | 60.000 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 36.07% | 35.76% | 35.42% | 32.81% | 33.64% | 33.75% |
Operating Margin | 4.71% | 4.93% | 4.86% | 3.48% | 4.96% | 5.05% |
Profit Margin | 4.05% | 2.98% | 3.26% | 2.77% | 3.06% | 3.07% |
Free Cash Flow Margin | - | -0.86% | -2.00% | 2.30% | 1.48% | -0.26% |
EBITDA | 21,282 | 21,153 | 18,140 | 13,293 | 16,409 | 16,106 |
EBITDA Margin | 7.28% | 7.55% | 7.27% | 5.78% | 6.95% | 7.05% |
D&A For EBITDA | 7,511 | 7,357 | 6,014 | 5,283 | 4,686 | 4,554 |
EBIT | 13,771 | 13,796 | 12,126 | 8,010 | 11,723 | 11,552 |
EBIT Margin | 4.71% | 4.93% | 4.86% | 3.48% | 4.96% | 5.05% |
Effective Tax Rate | 13.93% | 41.70% | 37.09% | 38.07% | 39.14% | 36.25% |